Haemorheological disturbances in hypertensive type 2 diabetic patients - Influence of antihypertensive therapy

Fundamental and Clinical Pharmacology

Volumn 21, Issue 4, 2007, Pages 387-396

  Kearney Schwartz, Anna ^a,b,c   Virion, Jean Marc ^a,b   Stoltz, Jean François ^c   Drouin, Pierre ^a,b   Zannad, Faiez ^a,b,c  

^a Ctr Hospitalier Univ de Nancy   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Antihypertensive treatment; Haemorheology; Hypertension; Type 2 diabetes

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FIBRINOGEN; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; METFORMIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY DIAMETER; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMATOCRIT; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA VISCOSITY; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SHEAR RATE; SHEAR STRESS; SYSTOLIC BLOOD PRESSURE;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VISCOSITY; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEMORHEOLOGY; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; STRESS, MECHANICAL;

EID: 34447510019     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00496.x     Document Type: Article

References (48)

1. Zannad F., Voisin P., Brunotte F. et al. Haemorhological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J. Hypertens. (1988) 6 293 297.
2. Zannad F., Stoltz J. Intérêt et methodes d'étude de l'hémorrhéologie en pathologie et pharmacologie vasculaires. Arch. Mal. Coeur Vaiss. (1990) 83 33 36.
3. Zannad F., Stoltz J. Blood rheology in arterial hypertension. J. Hypertens. Suppl. (1992) 10 (Suppl. 5) S69 S78.
4. Velcheva I., Antonova N., Titianova E., Damianov P. Hemorheological parameters in correlation with the risk factors for carotid atherosclerosis. Clin Hemorheol Microcirc (2006) 35 195 198.
5. Lee A. The role of rheological and haemostatic factors in hypertension. J. Hum. Hypertens. (1997) 11 767 776.
6. Linde T., Sandhagen B., Hagg A. et al. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J. Hypertens. (1993) 11 731 736.
7. Koblar V. Hemorheological changes in diabetes mellitus. Med. Arch. (1992) 46 19 21.
8. Ziegler O., Guerci B., Muller S. et al. Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: multivariate analysis. Metabolism (1994) 43 1182 1184.
9. Girerd X., London G., Boutouyrie P. et al. Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension (1996) 27 799 803.
10. Rampling M. Haemorheological disturbances in hypertension the influence of diabetes and smoking. Clin. Hemorheol. Microcirc. (1999) 21 183 187.
11. Muravyov A., Zaitsev L., Muravyov A. et al. Effects of ramipril and isradipin on hemorheological profiles in patients with arterial hypertension. Clin. Hemorheol. Microcirc. (1998) 18 185 190.
12. Shand B. Haemorheological effects of losartan and enalapril in patients with parenchymal disease and hypertension. J. Hum. Hypertens. (2000) 14 291 293.
13. Giannattasio C., Mangoni A., Failla M. et al. Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure. Hypertension (1995) 26 491 496.
14. Shimamoto H., Shimamoto Y. Lisinopril improves aortic compliance and renal flow. Comparison with nifedipine. Hypertension (1995) 25 327 334.
15. Boutouyrie P., Bussy C., Hayoz D. et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation (2000) 101 2601 2606.
16. Topouchian J., Asmar R., Sayegh F. et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke (1999) 30 1056 1064.
17. Asmar R., Benetos A., Chaouche-Teyara K. et al. Comparaison of effects of felodipine vs. hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am. J. Cardiol. (1993) 72 794 798.
18. Chalmers J., MacMahon S., Mancia G. et al. World Heath Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin. Exp. Hypertens. (1999) 21 1009 1060.
19. Tardy Y., Meister J.J., Perret F., Brunner H.R., Arditi M. Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin. Phys. Physiol. Meas. (1991) 12 39 54.
20. Khder Y., Briançon S., Petermann R., Quilliot D., Stoltz J.F., Drouin P., Zannad F. Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type II diabetes. J. Hypertens. (1998) 16 1619 1625.
21. Wang X., Stoltz J.F. Propriétés non-Newtoniennes du sang et contrainte pariétale dans un écoulement de Poiseuille. J. Mal. Vasc. (1995) 20 117 121.
22. Slonim A., Cristal N. Cardiovascular diseases, blood rheology and dihydropyridine calcium antagonists. J. Cardiovasc. Pharmacol. (1992) 19 (Suppl. 3) S96 S98.
23. Konstantinova E., Ivanova L., Tolstaya T., Mironova E. Rheological properties of blood and parameters of platelets aggregation in arterial hypertension. Clin. Hemorheol. Microcirc. (2006) 35 135 138.
24. Attali J., Valensi P. Diabète et hémorhéologie. Diabet. Metab. (1990) 16 1 6.
25. Valensi P., Mesangeau D., Paries J. et al. Erythrocyte rheology and heart hypertrophy in diabetes mellitus. J. Mal. Vasc. (1996) 21 185 187.
26. Le Devehat C., Khodabandehlou T., Vimeux M. Diabetes mellitus and fibrinogen hemorrheological and microcirculatory consequences. J. Mal. Vasc. (2000) 25 53 57.
27. Le Devehat C., Vimeux M., Khodabadehlou T. Blood rheology in patients with diabetes mellitus. Clin. Hemorheol. Microcirc. (2004) 30 297 300.
28. Coppola L., Verrazzo G., La Marca C. et al. Effect of insulin on blood rheology in non-diabetic subjects and in patients wiyh type 2 diabetes mellitus. Diabet. Med. (1997) 14 959 963.
29. Chong-Martinez B., Buchanan T.A., Wenby R.B. et al. Decreased red blood cell aggregation subsequent to improved glycaemic control in type 2 diabetes mellitus. Diabet. Med. (2003) 20 301 306.
30. Cinnara L., del Bollini A., Gayol M.C., Hernandez G.N. In vitro effect of insulin on rats erythrocytes rheological behaviour. Clin. Hemorheol. Microcirc. (2006) 35 367 373.
31. Martinez M., Vaya A., Server R. et al. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin. Hemorheol. Microcirc. (1998) 18 253 258.
32. Khder Y., Bray-des Boscs L., Aliot E. et al. Effects of blood pressure control on radial artery diameter and compliance in hypertensive patients. Am. J. Hypertens. (1997) 10 269 274.
33. Irace C., Carallo C., Crescenzo A. et al. DM is associated with lower Wall Shear stress of the common carotid artery. Diabetes (1999) 48 193 199.
34. Chien S. Blood rheology in myocardial infarction and hypertension. Biorheology (1986) 23 633 653.
35. Meiselman H.J. Hemorheologic alterations in hypertension: chicken or egg Clin. Hemorheol. Microcirc. (1999) 21 195 200.
36. Meiselmann H.J., Baskurt O.K. Hemorheology and hemodynamics: Dove andare Clin. Hemorheol. Microcirc. (2006) 35 37 43.
37. Khder Y., Bray-des Boscs L. et al. Calcium antagonists and thiazide diuretics have opposite effects on rheology and radial artery compliance in arterial hypertension: A randomized double-blind study. Fundam. Clin. Pharmacol. (1998) 12 457 462.
38. Tsuda Y., Satoh K., Kitadai M. et al. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension. Arzneimittelforschung (1997) 47 900 904.
39. Ding Y., Law H., Chou T. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients. J. Hum. Hypertens. (1994) 8 137 143.
40. Linde T., Sandhagen B., Hagg A. et al. Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study. J. Hum. Hypertens. (1996) 10 199 205.
41. Sowers J.R., Epstein M., Fröhlich E.D. Diabetes, hypertension a cardiovascular disease: an update. Hypertension (2001) 37 1053 1059.
42. Pollare T., Lithell H., Bern C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N. Engl. J. Med. (1989) 321 868 873.
43. Haffner S.M., Lehto S., Ronnemaa T., Pyoralla K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. (1998) 339 229 234.
44. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., Baron A.D. Insulin mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide realize. J. Clin. Invest. (1994) 94 1172 1179.
45. Heise T., Magnusson K., Heinemann L., Sawicki P.T. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension (1998) 32 243 248.
46. Westerbacka J., Vehkavaara S., Bergholm R., Wilkinson I., Cockroft J., Yki-Jarvinen H. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes (1999) 48 821 827.
47. Kaiser T., Helse T., Nosek L., Eckers U., Sawicki P.T. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. J Hypertension (2006) 24 1397 1403.
48. Ostman J., Asplund K., Bystedt T., Dahlof B., Jern S., Kiellstrom T., Lithell H. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. J. Intern. Med. (1998) 244 95 107.